Elevance Health Officer Mark Kaye Files Form 144 for $4.66M Proposed Stock Sale

Executive Summary

On October 22, 2026, Mark B Kaye, an Officer of Elevance Health, Inc. (NYSE: ELV), filed a Form 144 notice of proposed sale covering 10,584 shares of common stock. The aggregate market value of the proposed transaction is approximately $4,658,378.26, representing an implied share price of roughly $440.13.

Transaction Details

• Securities Offered: 10,584 shares of Common Stock.
• Aggregate Market Value: $4,658,378.26.
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
• Proposed Sale Date: October 22, 2026.
• Origin of Shares: The shares to be sold originated from multiple tranches of restricted stock and performance shares acquired directly from the issuer between October 2, 2025, and October 2, 2026.
• Prior Activity: The filer reported no other securities sold during the past three months.

Trading Significance

This proposed sale carries Medium significance. While the aggregate value exceeds $4.6M, the transaction represents approximately 0.005% of the company's 216,055,891 shares outstanding. The securities being liquidated were earned via executive compensation vesting events over the prior year, a routine wealth diversification and tax management pattern common among senior executives.